Protagonist Therapeutics
PTGX
$46.88
Share price
-3.06%
Change (1 day)
65.77%
Change (1 year)
Categories
Revenue for Protagonist Therapeutics (PTGX)
Revenue in 2024 (TTM): $0.43 Billion USD
According to Protagonist Therapeutics
's latest financial reports the company's current revenue (TTM 
) is $0.43 Billion USD. an increase over the revenue in the year 2023 that were of $60 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Protagonist Therapeutics from 2015 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | $0.43 B | 624.06% |
| 2023 | $60 M | 125.73% |
| 2022 | $26.58 M | -2.84% |
| 2021 | $27.35 M | -4.44% |
| 2020 | $28.62 M | 12293.07% |
| 2019 | $0.23 M | -99.25% |
| 2018 | $30.92 M | 54.14% |
| 2017 | $20.06 M | |
| 2016 | N/A | |
| 2015 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |